217 Publications (Page 6 of 9)
2013
Support service use and interest in support services among distressed family caregivers of lung cancer patients.
Mosher, Catherine EChampion, Victoria LHanna, NasserJalal, Shadia IFakiris, Achilles JBirdas, Thomas JOkereke, IkennaKesler, Kenneth AEinhorn, Lawrence HGiven, Barbara AMonahan, Patrick O and Ostroff, Jamie S
Psycho-oncology, vol. 22, (no. 7), pp. 1549-56, 2013/Jul. | Journal Article
 
Support service use and interest in support services among lung cancer patients.
Mosher, Catherine EHanna, NasserJalal, Shadia IFakiris, Achilles JEinhorn, Lawrence HBirdas, Thomas JKesler, Kenneth A and Champion, Victoria L
Lung cancer (Amsterdam, Netherlands), vol. 82, (no. 1), pp. 162-7, 2013/Oct. | Journal Article
 
Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.
Hanna, NasserMulshine, JamesWollins, Dana STyne, Courtney and Dresler, Carolyn
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 25), pp. 3147-3157, September 1, 2013. | Journal Article
2012
A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.
Wakelee, Heather ALee, Ju-WheiHanna, Nasser HTraynor, Anne MCarbone, David P and Schiller, Joan
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 7, (no. 10), pp. 1574-82, 2012/Oct. | Journal Article
 
A Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib (BAY 43–9006) in Previously Treated Non–Small-Cell Lung Cancer Patients: Eastern Cooperative Oncology Group Study E2501
Wakelee, Heather AWakelee, Heather A.Lee, Ju-WheiLee, Ju-WheiHanna, Nasser HHanna, Nasser H.Traynor, Anne M.Traynor, Anne MCarbone, David P.Carbone, David PSchiller, Joan H. and Schiller, Joan H
Journal of Thoracic Oncology, vol. 7, (no. 10), pp. 1582, October 2012. | Journal Article
 
A retrospective analysis of patients with intermediate-risk germ cell tumor (IRGCT) treated at Indiana University from 2000 to 2010
Albany, CostantineAlbany, CostantineAlbany, CostantineSatpute, Shailesh RSatpute, Shailesh RSatpute, Shailesh RBrames, Mary JBrames, Mary JBrames, Mary JSuleiman, YamanSuleiman, YamanSuleiman, YamanAl Nasrallah, NawarAl Nasrallah, NawarAl Nasrallah, NawarPerkins, Susan MPerkins, Susan MPerkins, Susan MHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 4534, 2012-05-20. | Journal Article
 
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.
Ortuzar, WaldoHanna, NasserPennella, EduardoPeng, GuangbinLanger, CoreyMonberg, Matthew and Scagliotti, Giorgio
Clinical lung cancer, vol. 13, (no. 1), pp. 24-30, January 2012. | Journal Article
 
Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group.
Schmitt, Jordan MSchmitt, Jordan MSommers, Scott RSommers, Scott RFisher, WilliamFisher, WilliamAnsari, RafatAnsari, RafatRobin, ErwinRobin, ErwinKoneru, KarunaKoneru, KarunaMcClean, JohnMcClean, JohnLiu, ZiyueLiu, ZiyueTong, YanTong, YanHanna, Nasser and Hanna, Nasser
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 7, (no. 4), pp. 760-3, 2012/Apr. | Journal Article
 
Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508)
Hanna, Nasser HDahlberg, Suzanne EleanorKolesar, JillHirsch, Fred RRamalingam, Suresh S and Schiller, Joan H
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 7516, 2012-05-20. | Journal Article
 
Two drugs versus one drug in non-small-cell lung cancer: are we asking the right questions?
Hanna, Nasser H
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 36), pp. 4454-5, 2012/Dec/20. | Journal Article
 
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology.
Jalal, Shadia IRiggs, H DMelnyk, ARichards, DAgarwala, ANeubauer, MAnsari, RGovindan, RamaswamyBruetman, DFisher, WBreen, TJohnson, C SYu, MenggangEinhorn, Lawrence H and Hanna, N
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 23, (no. 7), pp. 1730-8, 2012/Jul. | Journal Article
2011
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Tan, Eng-HuatGoss, Glenwood DSalgia, RaviBesse, BenjaminGandara, David RHanna, Nasser HYang, James CThertulien, RaymondWertheim, MichaelMazieres, JulienHensing, ThomasLee, ChristaGupta, NeerajPradhan, RajendraQian, JiangQin, QinScappaticci, Frank ARicker, Justin LCarlson, Dawn M and Soo, Ross A
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 6, (no. 8), pp. 1418-25, 2011/Aug. | Journal Article
 
Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.
Schmitt, J MSommers, S RFisher, W BAnsari, R HRobin, E LKoneru, KMcClean, J WLiu, Z and Hanna, N H
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 15_suppl), pp. e14661, May 20, 2011. | Journal Article
2010
Advanced non-small cell lung cancer: the role of maintenance therapy.
Agarwala, Anuj K and Hanna, Nasser H
Therapeutic advances in medical oncology, vol. 2, (no. 1), pp. 17-23, 2010/Jan. | Journal Article
 
Dimensional versus categorical use of the PHQ-9 depression scale among persons with non-small-cell lung cancer: a pilot study including quality-of-life comparisons.
Whitney, Kriscinda AWhitney, K.A.Steiner, Amy RSteiner, A.R.Lysaker, P.H.Lysaker, Paul HEstes, D.D.Estes, Deborah DHanna, Nasser H and Hanna, N.H.
The journal of supportive oncology, vol. 8, (no. 5), pp. 219-26, 2010 Sep-Oct. | Journal Article
 
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Barriger, R BFakiris, AchillesHanna, Nasser HYu, MenggangMantravadi, Prasad and Mc Garry, Ronald C
International journal of radiation oncology, biology, physics, vol. 78, (no. 5), pp. 1381-6, 2010/Dec/1. | Journal Article
 
Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group
Jalal, ShadiaJalal, Shadia IBedano, PabloBedano, PabloEinhorn, LawrenceEinhorn, Lawrence HBhatia, SumeetBhatia, SumeetAnsari, RafatAnsari, RafatBechar, NaftaliBechar, NaftaliKoneru, KarunaKoneru, KarunaGovindan, RamaswamyGovindan, RamaswamyWu, JingweiWu, JingweiYu, MenggangYu, MenggangSchneider, Bryan PSchneider, BryanHanna, Nasser and Hanna, Nasser
Journal of Thoracic Oncology, vol. 5, (no. 12), pp. 2011, December 2010. | Journal Article
 
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
Scagliotti, GiorgioNovello, SilviaPawel, JoachimReck, MartinPereira, JoséThomas, MichaelMiziara, JoséBalint, BeatrixMarinis, FilippoKeller, AlanArén, OsvaldoCsollak, MariaAlbert, IstvanBarrios, CarlosGrossi, FrancescoKrzakowski, MaciejCupit, LisaCihon, FrankDiMatteo, Sandra and Hanna, Nasser
Journal of Clinical Oncology, vol. 28, (no. 11), pp. 1842, 20100410. | Journal Article
 
Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non-Small Cell Lung Cancer Patients
Ellis, Peter MKaiser, RolfZhao, YihuaStopfer, PeterGyorffy, Steve and Hanna, Nasser
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 16, (no. 10), pp. 2889, 2010-May-15. | Journal Article
 
Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116
Casey, Erin MCasey, Erin MHarb, WaelHarb, WaelBradford, DanielBradford, DanielBufill, JoseBufill, JoseNattam, SreenivasaNattam, SreenivasaPatel, JyotiPatel, Jyoti DFisher, WilliamFisher, WilliamLatz, Jane ELatz, Jane ELi, XiaochunLi, XiaochunWu, JingweiWu, JingweiHanna, Nasser and Hanna, Nasser
Journal of Thoracic Oncology, vol. 5, (no. 11), pp. 1820, November 2010. | Journal Article
 
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli, CesareArdizzoni, AndreaDouillard, Jean-YvesHanna, Nasser HManegold, ChristianPerrone, FrancescoPirker, RobertRosell, RafaelShepherd, Frances ADe Petris, LuigiDi Maio, Massimo and de Marinis, Filippo
Lung cancer (Amsterdam, Netherlands), vol. 68, (no. 3), pp. 319-31, 2010/Jun. | Journal Article
2009
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study
Jalal, Shadia IJalal, ShadiaAnsari, RafatAnsari, RafatGovindan, RamaswamyGovindan, RamaswamyBhatia, SumeetBhatia, SumeetBruetman, DanielBruetman, DanielFisher, WilliamFisher, WilliamMasters, GregoryMasters, GregoryWhite, AngelaWhite, AngelaStover, DanielStover, DanielYu, MenggangYu, MenggangHanna, Nasser and Hanna, Nasser
Journal of Thoracic Oncology, vol. 4, (no. 1), pp. 96, January 2009. | Journal Article
 
Pemetrexed plus Cetuximab in Patients with Recurrent Non-small Cell Lung Cancer (NSCLC): A Phase I/II Study from the Hoosier Oncology Group
Jalal, Shadia IJalal, ShadiaWaterhouse, DavidWaterhouse, DavidEdelman, Martin JEdelman, Martin JNattam, SreenivasaNattam, SreenivasaAnsari, RafatAnsari, RafatKoneru, KarunaKoneru, KarunaClark, RomneeClark, RomneeRichards, ArthurRichards, ArthurWu, JingweiWu, JingweiYu, MenggangYu, MenggangBottema, BrianBottema, BrianWhite, AngelaWhite, AngelaHanna, Nasser and Hanna, Nasser
Journal of Thoracic Oncology, vol. 4, (no. 11), pp. 1424, November 2009. | Journal Article
 
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Scagliotti, GiorgioScagliotti, GiorgioScagliotti, GiorgioHanna, NasserHanna, NasserHanna, NasserFossella, FrankFossella, FrankFossella, FrankSugarman, KatherineSugarman, KatherineSugarman, KatherineBlatter, JohannesBlatter, JohannesBlatter, JohannesPeterson, PatrickPeterson, PatrickPeterson, PatrickSimms, LorindaSimms, LorindaSimms, LorindaShepherd, FrancesShepherd, Frances A and Shepherd, Frances
The Oncologist, vol. 14, (no. 3), pp. 263, 20090301. | Journal Article
 
The role of maintenance chemotherapy in advanced nonsmall cell lung cancer
Jalal, Shadia IJalal, ShadiaAdemuyiwa, Foluso OAdemuyiwa, FolusoHanna, Nasser H and Hanna, Nasser
Current Opinion in Oncology, vol. 21, (no. 2), pp. 115, 2009-March. | Journal Article